Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction
P Menasché, AA Hagège, JT Vilquin, M Desnos… - Journal of the American …, 2003 - jacc.org
Objectives: This phase I trial was designed to assess the feasibility and safety of autologous
skeletal myoblast transplantation in patients with severe ischemic cardiomyopathy …
skeletal myoblast transplantation in patients with severe ischemic cardiomyopathy …
Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up
T Siminiak, R Kalawski, D Fiszer, O Jerzykowska… - American heart …, 2004 - Elsevier
BACKGROUND: Experimental studies have shown that skeletal myoblast transplantation
into an area of postinfarction left ventricular injury results in an increase of segmental …
into an area of postinfarction left ventricular injury results in an increase of segmental …
Factors affecting functional outcome after autologous skeletal myoblast transplantation
B Pouzet, JT Vilquin, AA Hagège, M Scorsin… - The Annals of thoracic …, 2001 - Elsevier
Background. This study assessed the extent to which the initial degree of functional
impairment and the number of injected cells may influence the functional improvement …
impairment and the number of injected cells may influence the functional improvement …
The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation
P Menasché, O Alfieri, S Janssens, W McKenna… - Circulation, 2008 - Am Heart Assoc
Background—Phase I clinical studies have demonstrated the feasibility of implanting
autologous skeletal myoblasts in postinfarction scars. However, they have failed to …
autologous skeletal myoblasts in postinfarction scars. However, they have failed to …
[HTML][HTML] Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up
JJ Gavira, J Herreros, A Perez… - The Journal of thoracic …, 2006 - Elsevier
OBJECTIVE: To determine the feasibility and safety of skeletal myoblast transplantation in
patients with chronic myocardial infarction undergoing coronary artery bypass grafting …
patients with chronic myocardial infarction undergoing coronary artery bypass grafting …
Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients
AA Hagege, JP Marolleau, JT Vilquin, A Alhéritiere… - Circulation, 2006 - Am Heart Assoc
Background—Skeletal myoblast (SM) transplantation (Tx) in a post-myocardial infarction
(MI) scar experimentally improves left ventricular (LV) ejection fraction (EF). Short-term …
(MI) scar experimentally improves left ventricular (LV) ejection fraction (EF). Short-term …
Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up
PC Smits, RJM van Geuns, D Poldermans… - Journal of the American …, 2003 - jacc.org
Objectives: We report on the procedural and six-month results of the first percutaneous and
stand-alone study on myocardial repair with autologous skeletal myoblasts. Background …
stand-alone study on myocardial repair with autologous skeletal myoblasts. Background …
Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up
N Dib, RE Michler, FD Pagani, S Wright, DJ Kereiakes… - Circulation, 2005 - Am Heart Assoc
Background—Successful autologous skeletal myoblast transplantation into infarcted
myocardium in a variety of animal models has demonstrated improvement in cardiac …
myocardium in a variety of animal models has demonstrated improvement in cardiac …
Feasibility and safety of autologous myoblast transplantation in patients with ischemic cardiomyopathy
N Dib, P McCarthy, A Campbell, M Yeager… - Cell …, 2005 - journals.sagepub.com
Successful autologous skeletal myoblast transplantation into infarcted myocardium in a
variety of animal models has demonstrated improvement in cardiac function. We evaluated …
variety of animal models has demonstrated improvement in cardiac function. We evaluated …
Skeletal myoblasts as a therapeutic agent
P Menasché - Progress in cardiovascular diseases, 2007 - Elsevier
Cell transplantation is emerging as a new treatment designed to improve the poor outcome
of patients with cardiac failure. Its rationale is that implantation of contractile cells into …
of patients with cardiac failure. Its rationale is that implantation of contractile cells into …
相关搜索
- myoblast transplantation ischemic cardiomyopathy
- myoblast transplantation ventricular dysfunction
- myoblast transplantation feasibility and safety
- myoblast transplantation cohort of patients
- myoblast transplantation functional outcome
- skeletal myoblast cell therapy
- myoblast transplantation heart failure
- therapeutic agent skeletal myoblasts